Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
McIntyre v. Chelsea Therapeutics International, LTD. et al
Case Number:
3:12-cv-00213
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Faruqi & Faruqi
- Law Offices of James Scott Farrin
- Oxner & Permar
- Pomerantz LLP
- Robbins Geller
- Wilson Sonsini
- Wyrick Robbins
Companies
Sectors & Industries:
-
May 27, 2016
Chelsea Therapeutics Settles Investor Class Action For $5.5M
Chelsea Therapeutics International Inc. has agreed to pay $5.5 million in cash to settle an investor's putative securities class action stemming from alleged misstatements about its blood pressure drug Northera, the investor told a North Carolina federal court Friday.
-
August 26, 2015
Chelsea Therapeutics Class Action Left Intact, With Warning
A federal judge declined Wednesday to dismiss a securities class action against Chelsea Therapeutics International Ltd., but gave the parties a pointed recommendation to settle in light of the trouble similar suits have seen.